Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 12/20 | 0.55 |
| ▸ | CACNA1G | O43497 | 3/20 | 0.50 |
| ▸ | CACNA1I | Q9P0X4 | 3/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 6/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.45 |
| ▸ | MPO | P05164 | 1/20 | 0.45 |
| ▸ | TPO | P07202 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5869947 | 0.83 | HDAC1 (0.50) | HDAC1CACNA1GCACNA1ICYP19A1HDAC3 | |
| SCHEMBL10271012 | 0.83 | HDAC1 (0.50) | HDAC1CACNA1GCACNA1ICYP19A1HDAC3 | |
| SCHEMBL16578765 | 0.81 | HDAC1 (0.58) | HDAC1CYP19A1HDAC3HDAC4HDAC2 | |
| SCHEMBL18338327 | 0.81 | HDAC1 (0.46) | HDAC1CACNA1GCACNA1ICYP19A1HDAC3 | |
| SCHEMBL5151608 | 0.79 | RAB9A (0.56) | CYP19A1NPC1ALDH1A1RAB9ALMNA | |
| SCHEMBL28862067 | 0.79 | HDAC1 (0.50) | HDAC1CACNA1GCACNA1ICYP19A1HDAC3 | |
| SCHEMBL8011610 | 0.78 | CACNA1G (0.51) | HDAC1CACNA1GCACNA1ICYP19A1HDAC3 | |
| SCHEMBL11553968 | 0.78 | CYP19A1 (0.54) | CACNA1GCACNA1ICYP19A1CACNA1H | |
| SCHEMBL7374197 | 0.76 | CYP19A1 (0.51) | HDAC1CYP19A1HDAC3HDAC4HDAC2 | |
| SCHEMBL6031324 | 0.76 | HDAC1 (0.51) | HDAC1CACNA1GCACNA1IHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108431004-A | Heterocyclic compounds | 武田药品工业株式会社 | 2018-08-21 | — | — | CN | disclosed |
| US-7045532-B2 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2006-05-16 | — | — | US | disclosed |
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2004-04-29 | — | — | US | disclosed |
| WO-2002039997-A2 | ACE-2 MODULATING COMPOUNDS AND USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | ACE, ACE2, AGTR2 | HDAC1 236/4885CACNA1G 3249/4885CACNA1I 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.